{
    "2019-08-22": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Novo Nordisk Suing Mylan Over Generic Victoza Drug",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Suing",
                        "Mylan",
                        "Generic",
                        "Victoza",
                        "Drug"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Novo Nordisk's Fiasp Gets EC Approval for Label Expansion",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Fiasp",
                        "EC Approval",
                        "Label Expansion"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Denmark's Novo Nordisk files lawsuit against Mylan over patent",
                "features": {
                    "keywords": [
                        "Denmark",
                        "Novo Nordisk",
                        "files",
                        "lawsuit",
                        "Mylan",
                        "patent"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}